Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

Lipid nanoparticles successfully stopped the emergence and development of tumors cells, a new study reveals

UT Southwestern researchers have developed nanoparticles that can penetrate the physical barriers that surround tumors and reach cancer cells.

27 Jun 2022

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

The potential of CAR T-cell therapy for the treatment of solid tumors was unlocked in a preclinical trial by researchers at St. Jude Children’s Research Hospital who discovered a molecular mechanism. The findings were released in the journal Nature.

27 Jun 2022

Researchers demonstrate how tumors make immune cells less effective

Cedars-Sinai Cancer Center scientists found that cancerous tumors known as soft-tissue sarcomas generate a protein that changes immune cells from tumor attacking to tumor-promoting.

27 Jun 2022

Researchers discover effective therapy for pediatric T-acute leukemia

The most frequent type of malignancy in kids is acute lymphoblastic leukemia (ALL).

27 Jun 2022

New computer model helps identify mutations that drive tumor growth

Cancer cells can have thousands of mutations in their DNA. However, only a handful of those actually drive the progression of cancer; the rest are just along for the ride.

22 Jun 2022

New polymer material may pave the way for development of electronic pills and drug implants

Biomedicines are produced by living cells and are used to treat cancer and autoimmune diseases among other things.

17 Jun 2022

Researchers understand the mystery behind DNA rings

Professor Dr Anton Henssen of Charité – Universitätsmedizin Berlin and the Helmholtz Association’s Max Delbrück Center (MDC) for Molecular Medicine, along with a group of researchers from the United States and the United Kingdom, have received a grant for a Cancer Grand Challenge.

17 Jun 2022

Stanford scientists develop fingertip-sized millirobots to improve targeted drug delivery

If you've ever swallowed the same round tablet in hopes of curing everything from stomach cramps to headaches, you already know that medicines aren't always designed to treat precise pain points.

17 Jun 2022

New system offers a potential solution for wide-scale stem cell production

Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost.

17 Jun 2022

Novel nanoparticle therapeutic shows potential for treating human cancers

Researchers from Wake Forest University School of Medicine have discovered a possible new approach to treating solid tumors through the creation of a novel nanoparticle. Solid tumors are found in cancers such as breast, head and neck, and colon cancer.

15 Jun 2022

Discovery may reveal new ways to control plant growth

Understanding how plants process light is key to improving crop yields. Light helps plants know when to grow and flower at the right time.

15 Jun 2022

Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

Funding will enable the development of Spirea’s pipeline of antibody drug conjugate therapeutics for the treatment of solid tumours.

From Spirea 14 Jun 2022

Computational approach could enable large-scale analyses of tumor-specific total mRNA levels from patient samples

Researchers at The University of Texas MD Anderson Cancer Center have developed a new approach to quantify tumor-specific total mRNA levels from patient tumor samples, which contain both cancer and non-cancer cells.

14 Jun 2022

Study shows how probiotic bacteria may lower the risk of ER+ breast cancer

A new study presented at ENDO 2022, the Endocrine Society’s annual meeting in Atlanta, Ga., suggests that probiotic bacteria may improve the anti-cancer actions of the breast cancer drug tamoxifen as well as other endocrine-targeted therapies, potentially lowering the risk of estrogen receptive positive (ER+) breast cancer.

13 Jun 2022

ZDHHC18-mediated MDH2 palmitoylation upholds mitochondrial respiration and boosts ovarian cancer malignancy

To drive anabolic processes, epithelial ovarian cancer (EOC) is heavily reliant on the tricarboxylic acid (TCA) cycle and oxidative phosphorylation.

13 Jun 2022

Researchers utilize AI to reveal hitherto unknown 3D structures in rotavirus spike protein

The three types of rotavirus that cause gastroenteritis in individuals, known as groups A, B, and C, are the most well-known and afflict predominantly youngsters.

10 Jun 2022

Researchers discover a new interferon-gamma receptor signaling pathway

The interferon-gamma receptor (IFNgR) signaling pathway has been identified to be crucial for the vulnerability of glioblastoma tumors to death by CAR T-cell immunotherapy, according to researchers at Massachusetts General Hospital (MGH).

10 Jun 2022

Gene expression analysis helps identify genes that cause endocrine resistance in breast cancer

The most prevalent type of cancer detected in women is breast cancer (BC). BC is the second biggest cause of death among female cancer patients globally.

9 Jun 2022

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

Dotmatics, the leader in R&D scientific software connecting science, data, and decision-making, today announced the addition of Larry Samuelson as Chief Legal Officer and Neil Frye as Chief People Officer. The appointments further bolster the company’s executive team as the company extends the reach of its research and data solutions globally.

From Dotmatics 6 Jun 2022

$750,000 partnership grant supports the development of portable biosensors for detecting foodborne contaminants

An international team led by a University of Massachusetts Amherst food and environmental virologist has received a $750,000 USDA National Institute of Food and Agriculture (NIFA) partnership grant to develop and test portable, rapid biosensors capable of detecting noroviruses and mycotoxins in foods and agricultural products.

6 Jun 2022

Cancer News and Research

Lipid nanoparticles successfully stopped the emergence and development of tumors cells, a new study reveals

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

Researchers demonstrate how tumors make immune cells less effective

Researchers discover effective therapy for pediatric T-acute leukemia

New computer model helps identify mutations that drive tumor growth

New polymer material may pave the way for development of electronic pills and drug implants

Researchers understand the mystery behind DNA rings

Stanford scientists develop fingertip-sized millirobots to improve targeted drug delivery

New system offers a potential solution for wide-scale stem cell production

Novel nanoparticle therapeutic shows potential for treating human cancers

Discovery may reveal new ways to control plant growth

Spirea raises £2.4M ($3M) to develop antibody drug conjugates in cancer

Computational approach could enable large-scale analyses of tumor-specific total mRNA levels from patient samples

Study shows how probiotic bacteria may lower the risk of ER+ breast cancer

ZDHHC18-mediated MDH2 palmitoylation upholds mitochondrial respiration and boosts ovarian cancer malignancy

Researchers utilize AI to reveal hitherto unknown 3D structures in rotavirus spike protein

Researchers discover a new interferon-gamma receptor signaling pathway

Gene expression analysis helps identify genes that cause endocrine resistance in breast cancer

Dotmatics Strengthens Leadership Team as it Continues to Invest in Organization Capabilities and Accelerate Growth

$750,000 partnership grant supports the development of portable biosensors for detecting foodborne contaminants

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics